Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current HIV/AIDS Reports
Published in: Current HIV/AIDS Reports 5/2021

01-10-2021 | Human Immunodeficiency Virus | Behavioral-Bio-Medical Interface (RJ DiClemente and JL Brown, Section Editors)

A Review of Interventions to Enhance HIV Medication Adherence

Authors: Laura B. Whiteley, Elizabeth M. Olsen, Kayla K. Haubrick, Enyonam Odoom, Nicholas Tarantino, Larry K. Brown

Published in: Current HIV/AIDS Reports | Issue 5/2021

Login to get access

Abstract

Purpose of Review

Adherence to antiretroviral treatment (ART) is crucial for the successful treatment of HIV. Unfortunately, it is estimated that 45% of persons living with HIV (PLWH) have poor adherence to ART. To provide health care professionals and PLWH with effective tools for supporting adherence, researchers have investigated the effectiveness of psychosocial interventions to enhance adherence to ART. In this paper, interventional studies, systematic reviews, and meta-analyses that examine ART adherence interventions for PLWH are reviewed.

Recent Findings

There is great variability among interventions in terms of quality, sample, measures, and outcome characteristics. Despite a diverse and wide-ranging assortment of ART adherence interventions, consistent lessons have been learned. Interventions that focus on individual and interpersonal factors have been effective for improving ART adherence; however, the improvement in adherence tends to be short-lived. Additionally, interventions are most successful when tailored to those at risk for poor adherence. Finally, theory-based interventions are more likely to be effective than non-theory-based interventions.

Summary

A variety of individual-level psychological interventions have been shown to be effective in improving ART adherence in the short term. Digital and mobile interventions have the potential to improve dissemination and implementation of these evidence-based interventions and could be used to extend intervention effects. Future interventions that address issues of accessibility, inequality, structural and institutional barriers to ART adherence should also be tested and prioritized. Implementation science frameworks can be used to assess and address issues of accessibility and systematic barriers to care.
Literature
1.
Howard AA, Arnsten JH, Lo Y, Vlahov D, Rich JD, Schuman P, et al. A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS England. 2002;16:2175–82.
2.
Knobel H, Alonso J, Casado JL, Collazos J, González J, Ruiz I, et al. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study. AIDS England. 2002;16:605–13.
3.
Knobel H, Guelar A, Carmona A, Espona M, González A, López-Colomés JL, et al. Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors. AIDS Patient Care STDS United States. 2001;15:193–9.
4.
Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med United States. 2000;133:21–30.
5.
6.
7.
8.
World Health Organization. Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations. WHO Guidel. 2014;
9.
Mugavero MJ, Amico KR, Horn T, Thompson MA. The state of engagement in HIV care in the United States: from cascade to continuum to control. Clin Infect Dis an Off Publ Infect Dis Soc Am. United States. 2013;57:1164–71.
10.
Byrd KK, Hou JG, Hazen R, Kirkham H, Suzuki S, Clay PG, et al. antiretroviral adherence level necessary for HIV viral suppression using real-world data. J Acquir Immune Defic Syndr. 2019;82:245–51.PubMedPubMedCentral
11.
12.
Metsch LR, Pereyra M, Messinger S, Del Rio C, Strathdee SA, Anderson-Mahoney P, et al. HIV transmission risk behaviors among HIV-infected persons who are successfully linked to care. Clin Infect Dis an Off Publ Infect Dis Soc Am. United States. 2008;47:577–84.
13.
Mannheimer S, Friedland G, Matts J, Child C, Chesney M. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis an Off Publ Infect Dis Soc Am. United States. 2002;34:1115–21.
14.
Golin CE, Liu H, Hays RD, Miller LG, Beck CK, Ickovics J, et al. A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med. 2002;17:756–65.PubMedPubMedCentral
15.
Moss AR, Hahn JA, Perry S, Charlebois ED, Guzman D, Clark RA, et al. Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective study. Clin Infect Dis an Off Publ Infect Dis Soc Am. United States. 2004;39:1190–8.
16.
Thrasher AD, Earp JAL, Golin CE, Zimmer CR. Discrimination, distrust, and racial/ethnic disparities in antiretroviral therapy adherence among a national sample of HIV-infected patients. J Acquir Immune Defic Syndr. United States. 2008;49:84–93.
17.
Simoni JM, Huh D, Wilson IB, Shen J, Goggin K, Reynolds NR, et al. Racial/Ethnic disparities in ART adherence in the United States: findings from the MACH14 study. J Acquir Immune Defic Syndr. 2012;60:466–72.PubMedPubMedCentral
18.
Kyser M, Buchacz K, Bush TJ, Conley LJ, Hammer J, Henry K, et al. Factors associated with non-adherence to antiretroviral therapy in the SUN study. AIDS Care England. 2011;23:601–11.
19.
England MJ, Butler AS, Gonzalez ML, editors. Psychosocial interventions for mental and substance use disorders: a framework for establishing evidence-based standards. Washington (DC); 2015.
20.
World Health Organization. Withdrawal Management. Clin guidel withdrawal manag treat drug depend closed settings. 2009.
21.
Adefolalu AO. Cognitive-behavioural theories and adherence: application and relevance in antiretroviral therapy. South Afr J HIV Med. 2018;19.
22.
Amico KR, Barta W, Konkle-Parker DJ, Fisher JD, Cornman DH, Shuper PA, et al. The information-motivation-behavioral skills model of ART adherence in a deep south HIV+ clinic sample. AIDS Behav. 2009;
23.
Whiteley L, Brown LK, Mena L, Craker L, Arnold T. Enhancing health among youth living with HIV using an iPhone game. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV. 2018;30.
24.
25.
Cunningham WE, Weiss RE, Nakazono T, Malek MA, Shoptaw SJ, Ettner SL, et al. Effectiveness of a peer navigation intervention to sustain viral suppression among HIV-positive men and transgender women released from jail: the LINK LA randomized clinical trial. JAMA Intern Med. 2018;178:542–53.PubMedPubMedCentral
26.
Pagan-Ortiz ME, Goulet P, Kogelman L, Levkoff SE, Weitzman PF. Feasibility of a texting intervention to improve medication adherence among older HIV+ African Americans: A mixed-method pilot study. Gerontol Geriatr Med. 2019;5:2333721419855662.PubMedPubMedCentral
27.
Tanner AE, Mann L, Song E, Alonzo J, Schafer K, Arellano E, et al. Wecare: A social media–based intervention designed to increase HIV care linkage, retention, and health outcomes for racially and ethnically diverse young MSM. AIDS Educ Prev. 2016;
28.
Garofalo R, Kuhns LM, Hotton A, Johnson A, Muldoon A, Rice D. A randomized controlled trial of personalized text message reminders to promote medication adherence among HIV-positive adolescents and young adults. AIDS Behav. 2016;
29.
Hightow-Weidman L, Muessig K, Knudtson K, Srivatsa M, Lawrence E, LeGrand S, et al. A gamified smartphone app to support engagement in care and medication adherence for HIV-positive young men who have sex with men (AllyQuest): development and pilot study. J Med Internet Res. 2018.
30.
Bandura A. Health promotion by social cognitive means. Heal Educ Behav Off Publ Soc Public Heal Educ. United States. 2004;31:143–64.
31.
Folkman S. Personal control and stress and coping processes: a theoretical analysis. J Pers Soc Psychol. 1984;46:839–52.PubMed
32.
Bova C, Burwick TN, Quinones M. Improving women’s adjustment to HIV infection: results of the Positive Life Skills Workshop Project. J Assoc Nurses AIDS Care. United States. 2008;19:58–65.
33.
34.
Cummins J. Negotiating identities: education for empowerment in a diverse society. Ontario, Canada: California Association of Bilingual Education; 2001.
35.
36.
Holstad MMD, DiIorio C, Magowe MKM. Motivating HIV positive women to adhere to antiretroviral therapy and risk reduction behavior: The KHARMA Project. Online J Issues Nurs. 2006.
37.
de Bruin M, Hospers HJ, van Breukelen GJP, Kok G, Koevoets WM, Prins JM. Electronic monitoring-based counseling to enhance adherence among HIV-infected patients: a randomized controlled trial. Health Psychol. 2010.
38.
39.
Sabin LL, Bachman DeSilva M, Gill CJ, Zhong L, Vian T, Xie W, et al. Improving adherence to antiretroviral therapy with triggered real-time text message reminders: the China adherence through technology study. J Acquir Immune Defic Syndr. 2015;69:551–9.PubMedPubMedCentral
40.
41.
Bouris A, Jaffe K, Eavou R, Liao C, Kuhns L, Voisin D, et al. Project nGage: results of a randomized controlled trial of a dyadic network support intervention to retain young black men who have sex with men in HIV care. AIDS Behav [Internet]. 2017;21:3618–29. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​29079949
42.
Naar-King S, Outlaw AY, Sarr M, Parsons JT, Belzer M, Macdonell K, et al. Motivational Enhancement System for Adherence (MESA): pilot randomized trial of a brief computer-delivered prevention intervention for youth initiating antiretroviral treatment. J Pediatr Psychol. 2013;38:638–48.PubMedPubMedCentral
43.
44.
Blashill AJ, Safren SA, Wilhelm S, Jampel J, Taylor SW, O’Cleirigh C, et al. Cognitive behavioral therapy for body image and self-care (CBT-BISC) in sexual minority men living with HIV: A randomized controlled trial. Heal Psychol Off J Div Heal Psychol Am Psychol Assoc. 2017;36:937–46.
45.
Madhombiro M, Dube B, Dube M, Zunza M, Chibanda D, Rusakaniko S, et al. Intervention for alcohol use disorders at an HIV care clinic in Harare: a pilot and feasibility study. Addict Sci Clin Pract. 2019;14:16.PubMedPubMedCentral
46.
Kahler CW, Pantalone DW, Mastroleo NR, Liu T, Bove G, Ramratnam B, et al. Motivational interviewing with personalized feedback to reduce alcohol use in HIV-infected men who have sex with men: a randomized controlled trial. J Consult Clin Psychol. 2018;86:645–56.PubMedPubMedCentral
47.
Madhombiro M, Dube-Marimbe B, Dube M, Chibanda D, Zunza M, Rusakaniko S, et al. A cluster randomised controlled trial protocol of an adapted intervention for alcohol use disorders in people living with HIV and AIDS: impact on alcohol use, general functional ability, quality of life and adherence to HAART. BMC Psychiatry. 2017;17:44.PubMedPubMedCentral
48.
Rollnick S, Allison J. The Essential Handbook of Treatment and prevention of alcohol problems. Essent Handb Treat Prev Alcohol Probl. 2004.
49.
50.
51.
52.
Ruria EC, Masaba R, Kose J, Woelk G, Mwangi E, Matu L, et al. Optimizing linkage to care and initiation and retention on treatment of adolescents with newly diagnosed HIV infection. AIDS [Internet]. Lippincott Williams & Wilkins; 2017;31 Suppl 3:S253–60. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​28665883
53.
54.
55.
Swendeman D, Rotheram-Borus MJ. Innovation in sexually transmitted disease and HIV prevention: Internet and mobile phone delivery vehicles for global diffusion. Curr. Opin. Psychiatry. Swendeman, Dallas: Center for Community Health, University of California, Los Angeles, 10920 Wilshire Boulevard, Suite 350, Los Angeles, CA, US, 90024, dswendeman@mednet.ucla.edu: Lippincott Williams & Wilkins; 2010. p. 139–44.
56.
Claborn KR, Fernandez A, Wray T, Ramsey S. Computer-based HIV adherence promotion interventions: a systematic review: Translation Behavioral Medicine. Transl Behav Med. 2015;5:294–306.PubMedPubMedCentral
57.
Fisher JD, Amico KR, Fisher WA, Cornman DH, Shuper PA, Trayling C, et al. Computer-based intervention in HIV clinical care setting improves antiretroviral adherence: the LifeWindows Project. AIDS Behav United States. 2011;15:1635–46.
58.
Hersch RK, Cook RF, Billings DW, Kaplan S, Murray D, Safren S, et al. Test of a web-based program to improve adherence to HIV medications. AIDS Behav. 2013;17:2963–76.PubMed
59.
Ownby RL, Waldrop-Valverde D, Caballero J, Jacobs RJ. Baseline medication adherence and response to an electronically delivered health literacy intervention targeting adherence. Neurobehav HIV Med. 2012;4:113–21.PubMedPubMedCentral
60.
61.
Encyclopedia of Behavioral Medicine. Encycl. Behav. Med. Springer Science+Business Media; 2013
62.
Demonceau J, Ruppar T, Kristanto P, Hughes DA, Fargher E, Kardas P, et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs. 2013;73:545–62.PubMedPubMedCentral
63.
Vrijens B, Urquhart J, White D. Electronically monitored dosing histories can be used to develop a medication-taking habit and manage patient adherence. Expert Rev Clin Pharmacol England. 2014;7:633–44.
64.
Mbuagbaw L, Hajizadeh A, Wang A, Mertz D, Lawson DO, Smieja M, et al. Overview of systematic reviews on strategies to improve treatment initiation, adherence to antiretroviral therapy and retention in care for people living with HIV: part 1. BMJ Open. 2020;10:e034793.PubMedPubMedCentral
65.
Craker L, Tarantino N, Whiteley L, Brown L. Measuring antiretroviral adherence among young people living with HIV: observations from a real-time monitoring device versus self-report. AIDS Behav [Internet]. 2019;23:2138–45 Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​30888573.
66.
Van der Elst EM, Mbogua J, Operario D, Mutua G, Kuo C, Mugo P, et al. High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya. AIDS Behav. 2013;17:2162–72.PubMedPubMedCentral
67.
68.
Mayer JE, Fontelo P. Meta-analysis on the effect of text message reminders for HIV-related compliance. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV. 2017;29:409–17.
69.
Taylor D, Lunny C, Lolić P, Warje O, Geldman J, Wong T, et al. Effectiveness of text messaging interventions on prevention, detection, treatment, and knowledge outcomes for sexually transmitted infections (STIs)/HIV: a systematic review and meta-analysis. Syst Rev. 2019;8:12.PubMedPubMedCentral
70.
Abiodun O, Ladi-Akinyemi B, Olu-Abiodun O, Sotunsa J, Bamidele F, Adepoju A, et al. A single-blind, parallel design RCT to assess the effectiveness of SMS Reminders in Improving ART adherence among adolescents living with HIV (STARTA Trial). United States: J Adolesc Heal Off Publ Soc Adolesc Med; 2020.
71.
Cao B, Gupta S, Wang J, Hightow-Weidman LB, Muessig KE, Tang W, et al. Social media interventions to promote HIV testing, linkage, adherence, and retention: systematic review and meta-analysis. J Med Internet Res. 2017;19:e394.PubMedPubMedCentral
72.
Horvath KJ, Oakes JM, Rosser BRS, Danilenko G, Vezina H, Amico KR, et al. Feasibility, acceptability and preliminary efficacy of an online peer-to-peer social support ART adherence intervention. AIDS Behav. 2013;17:2031–44.PubMedPubMedCentral
73.
Dulli L, Ridgeway K, Packer C, Murray KR, Mumuni T, Plourde KF, et al. A social media-based support group for youth living with HIV in Nigeria (SMART Connections): randomized controlled trial. J Med Internet Res. 2020;22:e18343.PubMedPubMedCentral
74.
Horvath KJ, Amico KR, Erickson D, Ecklund AM, Martinka A, DeWitt J, et al. Thrive With Me: protocol for a randomized controlled trial to test a peer support intervention to improve antiretroviral therapy adherence among men who have sex with men. JMIR Res Protoc. 2018;7:e10182.PubMedPubMedCentral
75.
LeGrand S, Muessig KE, McNulty T, Soni K, Knudtson K, Lemann A, et al. Epic allies: development of a gaming app to improve antiretroviral therapy adherence among young HIV-positive men who have sex with men. JMIR Serious Games. 2016;4:e6.PubMedPubMedCentral
76.
77.
Hightow-Weidman LB, Muessig KE, Bauermeister JA, LeGrand S, Fiellin LE. The future of digital games for HIV prevention and care. Curr. Opin. HIV AIDS. 2017.
78.
Ritterfeld U, Cody M, Vorderer P. Serious games: mechanisms and effects. Serious Games Mech. Eff. 2009.
79.
LeGrand S, Muessig KE, Platt A, Soni K, Egger JR, Nwoko N, et al. Epic allies, a gamified mobile phone app to improve engagement in care, antiretroviral uptake, and adherence among young men who have sex with men and young transgender women who have sex with men: protocol for a randomized controlled trial. JMIR Res Protoc. 2018;7:e94.PubMedPubMedCentral
80.
Baranowski T, Baranowski J, Cullen KW, Marsh T, Islam N, Zakeri I, et al. Squire’s Quest! Dietary outcome evaluation of a multimedia game. Am J Prev Med Netherlands. 2003;24:52–61.
81.
Brown SJ, Lieberman DA, Germeny BA, Fan YC, Wilson DM, Pasta DJ. Educational video game for juvenile diabetes: results of a controlled trial. Med Inform (Lond). England. 1997;22:77–89.
82.
Kato PM, Cole SW, Bradlyn AS, Pollock BH. A video game improves behavioral outcomes in adolescents and young adults with cancer: a randomized trial. Pediatrics United States. 2008;122:e305–17.
83.
Fogg B. A behavior model for persuasive design. ACM Int Conf Proceeding Ser. 2009.
84.
Medich M, Swendeman DT, Comulada WS, Kao UH, Myers JJ, Brooks RA, et al. Promising approaches for engaging youth and young adults living with hiv in hiv primary care using social media and mobile technology interventions: protocol for the spns social media initiative. JMIR Res Protoc. 2019.
85.
Dillingham R, Ingersoll K, Flickinger TE, Waldman AL, Grabowski M, Laurence C, et al. PositiveLinks: a mobile health intervention for retention in HIV care and clinical outcomes with 12-month follow-up. AIDS Patient Care STDS. Dillingham, Rebecca: UVA School of Medicine, P.O. Box 801379, Charlottesville, VA, US, 22908, rd8v@virginia.edu: Mary Ann Liebert, Inc.; 2018. p. 241–50.
86.
87.
Chibanda D. Depression and HIV: integrated care towards 90-90-90. Int Health. 2017.
88.
Rubin LH, Maki PM. HIV, depression, and cognitive impairment in the era of effective antiretroviral therapy. Curr HIV/AIDS Rep. 2019;16:82–95.PubMedPubMedCentral
89.
Enane LA, Vreeman RC, Foster C. Retention and adherence: global challenges for the long-term care of adolescents and young adults living with HIV. Curr Opin HIV AIDS United States. 2018;13:212–9.
90.
Centers for Disease Control and Prevention (CDC). HIV and Youth. 2020.
91.
92.
93.
Whiteley L, Brown LK, Mena L, Craker L, Arnold T. Enhancing health among youth living with HIV using an iPhone game. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV. 2018;30:21–33.
94.
Ghidei L, Simone MJ, Salow MJ, Zimmerman KM, Paquin AM, Skarf LM, et al. Aging, antiretrovirals, and adherence: a meta analysis of adherence among older HIV-infected individuals. Drugs Aging. 2013;30:809–19.PubMed
95.
Johnson CJ, Heckman TG, Hansen NB, Kochman A, Sikkema KJ. Adherence to antiretroviral medication in older adults living with HIV/AIDS: a comparison of alternative models. AIDS Care. 2009;21:541–51.PubMedPubMedCentral
96.
McCoy K, Waldrop-Valverde D, Balderson BH, Mahoney C, Catz S. Correlates of antiretroviral therapy adherence among HIV-infected older adults. J Int Assoc Provid AIDS Care. 2016;15:248–55.PubMed
97.
Centers for Disease Control and Prevention (CDC). HIV and Women. 2020.
98.
99.
Brown JL, Littlewood RA, Vanable PA. Social-cognitive correlates of antiretroviral therapy adherence among HIV-infected individuals receiving infectious disease care in a medium-sized northeastern US city. AIDS Care [Internet]. 2013/01/11. 2013;25:1149–58. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​23311323
100.
Lambert CC, Mugavero MJ, Najjar YS, Enah C, Guthrie BJ. The state of adherence to HIV care in Black women. J Assoc Nurses AIDS Care. 2018;29:487–503.PubMedPubMedCentral
101.
Pellowski JA, Price DM, Harrison AD, Tuthill EL, Myer L, Operario D, et al. A systematic review and meta-analysis of antiretroviral therapy (ART) adherence interventions for women living with HIV. AIDS Behav [Internet]. 2019;23:1998–2013. Available from. 2019. https://​doi.​org/​10.​1007/​s10461-018-2341-9.
102.
103.
104.
105.
106.
107.
Dowshen N, Matone M, Luan X, Lee S, Belzer M, Fernandez MI, et al. Behavioral and health outcomes for HIV+ young transgender women (YTW) linked to and engaged in medical care. LGBT Heal. 2016;3:162–7.
108.
109.
110.
Centers for Disease Control and Prevention (CDC). HIV basics: basic statistics. Div. HIV/AIDS Prev. Natl. Cent. HIV/AIDS, Viral Hepatitis, STD, TB Prev. 2021.
111.
112.
Quinn KG, Voisin DR. ART adherence among men who have sex with men living with HIV: key challenges and opportunities. Curr HIV/AIDS Rep. 2020;17:290–300.PubMedPubMedCentral
113.
Mutchler MG, Bogart LM, Klein DJ, Wagner GJ, Klinger IA, Tyagi K, et al. Age matters: differences in correlates of self-reported HIV antiretroviral treatment adherence between older and younger Black men who have sex with men living with HIV. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV. 2019;31:965–72.
114.
Crepaz N, Dong X, Wang X, Hernandez AL, Hall HI. Racial and ethnic disparities in sustained viral suppression and transmission risk potential among persons receiving HIV care - United States, 2014. MMWR Morb Mortal Wkly Rep. 2018;67:113–8.PubMedPubMedCentral
115.
Pence BW, Gaynes BN, Williams Q, Modi R, Adams J, Quinlivan EB, et al. Assessing the effect of Measurement-Based Care depression treatment on HIV medication adherence and health outcomes: rationale and design of the SLAM DUNC Study. Contemp Clin Trials. 2012;33:828–38.PubMedPubMedCentral
116.
Pence BW, Gaynes BN, Adams JL, Thielman NM, Heine AD, Mugavero MJ, et al. The effect of antidepressant treatment on HIV and depression outcomes: Results from a randomized trial. AIDS. 2015;29:1975–86.PubMed
117.
Turan B, Rice WS, Crockett KB, Johnson M, Neilands TB, Ross SN, et al. Longitudinal association between internalized HIV stigma and antiretroviral therapy adherence for women living with HIV: the mediating role of depression. AIDS. 2019;33:571–6.PubMed
118.
Sin NL, DiMatteo MR. Depression treatment enhances adherence to antiretroviral therapy: a meta-analysis. Ann Behav Med. 2014;47:259–69.PubMed
119.
Turner BJ, Laine C, Cosler L, Hauck WW. Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. J Gen Intern Med. 2003;18:248–57.PubMedPubMedCentral
120.
Akincigil A, Wilson IB, Walkup JT, Siegel MJ, Huang C, Crystal S. Antidepressant treatment and adherence to antiretroviral medications among privately insured persons with HIV/AIDS. AIDS Behav. 2011;
121.
Horberg MA, Silverberg MJ, Hurley LB, Towner WJ, Klein DB, Bersoff-Matcha S, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr. 2008;
122.
Kong MC, Nahata MC, Lacombe VA, Seiber EE, Balkrishnan R. Association between race, depression, and antiretroviral therapy adherence in a low-income population with HIV infection. J Gen Intern Med. 2012;
123.
Passchier RV, Abas MA, Ebuenyi ID, Pariante CM. Effectiveness of depression interventions for people living with HIV in sub-Saharan Africa: a systematic review & meta-analysis of psychological & immunological outcomes. Brain Behav Immun. 2018;73:261–73.PubMed
124.
Brown LK, Kennard BD, Emslie GJ, Mayes TL, Whiteley LB, Bethel J, et al. Effective treatment of depressive disorders in medical clinics for adolescents and young adults living with HIV: a controlled trial. J Acquir Immune Defic Syndr. 2016;71:38–46.PubMedPubMedCentral
125.
Brown L, Chernoff M, Kennard B, Emslie G, Shapiro D, Lypen K, AW SBuisson, Whiteley L, Traite S, Krotje C, Harriff L and ET for the I 2020 team. Site-randomized controlled trial of a combined cognitive behavioral therapy and a medication management algorithm for treatment of depression among youth living with HIV in the United States. 23rd Int AIDS Conf (AIDS 2020).
126.
Graves JC, Elyanu P, Schellack CJ, Asire B, Prust ML, Prescott MR, et al. Impact of a family clinic day intervention on paediatric and adolescent appointment adherence and retention in antiretroviral therapy: a cluster randomized controlled trial in Uganda. PLoS One. 2018;13:e0192068.PubMedPubMedCentral
127.
Claborn K, Becker S, Operario D, Safren S, Rich JD, Ramsey S. Adherence intervention for HIV-infected persons who use drugs: adaptation, open trial, and pilot randomized hybrid type 1 trial protocol. Addict Sci Clin Pract. 2018;13:12.PubMedPubMedCentral
128.
Altice FL, Maru DSR, Bruce RD, Springer SA, Friedland GH. Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: A prospective, randomized, controlled trial. Clin Infect Dis. 2007;45:770–8.PubMed
129.
Fanucchi L, Springer SA, Korthuis PT. Medications for treatment of opioid use disorder among persons living with HIV. Curr HIV/AIDS Rep. 2019;16:1–6.PubMedPubMedCentral
130.
Lucas GM, Mullen BA, Weidle PJ, Hader S, McCaul ME, Moore RD. Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups. Clin Infect Dis an Off Publ Infect Dis Soc Am. United States. 2006;42:1628–35.
131.
González-Álvarez S, Madoz-Gúrpide A, Parro-Torres C, Hernández-Huerta D, Mangado EO. Relationship between alcohol consumption, whether linked to other substance use or not, and antiretroviral treatment adherence in HIV+ patients. Adicciones. 2019.
132.
Perlman DC, Jordan AE. The Syndemic of Opioid Misuse, Overdose, HCV, and HIV: structural-level causes and interventions. Curr HIV/AIDS Rep. 2018;15:96–112.PubMedPubMedCentral
133.
van Luenen S, Garnefski N, Spinhoven P, Spaan P, Dusseldorp E, Kraaij V. The benefits of psychosocial interventions for mental health in people living with HIV: a systematic review and meta-analysis. AIDS Behav. 2018.
134.
Centers for Disease Control and Prevention (CDC). Complete listing of medication adherence evidence-based behavioral interventions. 2020.
135.
Baumann AA, Cabassa LJ. Reframing implementation science to address inequities in healthcare delivery. BMC Health Serv Res. 2020;
136.
Eisman AB, Kilbourne AM, Dopp AR, Saldana L, Eisenberg D. Economic evaluation in implementation science: making the business case for implementation strategies. Psychiatry Res. 2020;283:112433.PubMed
137.
Roberts SLE, Healey A, Sevdalis N. Use of health economic evaluation in the implementation and improvement science fields - a systematic literature review. Implement. Sci. 2019
Metadata
Title
A Review of Interventions to Enhance HIV Medication Adherence
Authors
Laura B. Whiteley
Elizabeth M. Olsen
Kayla K. Haubrick
Enyonam Odoom
Nicholas Tarantino
Larry K. Brown
Publication date
01-10-2021
Publisher
Springer US
Published in
Current HIV/AIDS Reports / Issue 5/2021
Print ISSN: 1548-3568
Electronic ISSN: 1548-3576
DOI
https://doi.org/10.1007/s11904-021-00568-9

Other articles of this Issue 5/2021

Current HIV/AIDS Reports 5/2021 Go to the issue

Central Nervous System and Cognition (SS Spudich, Section Editor)

Advances in the Experimental Models of HIV-Associated Neurological Disorders

Complications of HIV and Antiretroviral Therapy (GA McComsey, Section Editor)

Cardiovascular Disease Risk Among Transgender People with HIV

The Science of Prevention (R Heffron and K Ngure, Section Editors)

Lessons Learned from Longer Acting Reversible Contraception Applied to Longer Acting HIV Prevention Technologies

Complications of HIV and Antiretroviral Therapy (GA McComsey, Section Editor)

People living with HIV and the emerging field of chronic pain—what is known about epidemiology, etiology, and management

Complications of HIV and Antiretroviral Therapy (GA McComsey, Section Editor)

Cardiometabolic Complications in Youth With Perinatally Acquired HIV in the Era of Antiretroviral Therapy

HIV Pathogenesis and Treatment (AL Landay and NS Utay, Section Editors)

Analytical Treatment Interruption in HIV Trials: Statistical and Study Design Considerations
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits